Lipocine Inc. (NASDAQ:LPCN – Get Free Report) shares crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $5.70 and traded as low as $4.90. Lipocine shares last traded at $5.01, with a volume of 25,765 shares traded. Analyst Ratings Changes Separately, StockNews.com began coverage on […]
Checchi Capital Advisers LLC lifted its holdings in ConocoPhillips (NYSE:COP – Free Report) by 4.2% in the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 14,201 shares of the energy producer’s stock after purchasing an additional 569 shares during the period. Checchi Capital Advisers LLC’s holdings in ConocoPhillips […]
Lipocine (NASDAQ:LPCN) Coverage Initiated by Analysts at StockNews com themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Research analysts at StockNews.com began coverage on shares of Lipocine (NASDAQ:LPCN – Get Free Report) in a research note issued to investors on Thursday. The brokerage set a “buy” rating on the specialty pharmaceutical company’s stock. Lipocine Stock Performance Shares of NASDAQ:LPCN opened at $5.09 on Thursday. Lipocine has a 52 week low of $3.30 […]
Keating Investment Counselors Inc. cut its stake in shares of ConocoPhillips (NYSE:COP – Free Report) by 3.1% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 10,936 shares of the energy producer’s stock after selling 350 shares during the period. Keating Investment Counselors Inc.’s holdings […]